Assertio Therapeutics Inc (ASRT) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $23.50 (+0.09%), Market cap $0.15B, 52-week low–high $0.62 ~ $23.44.
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for t
Financial statements, price targets, institutional (13F) holdings and related news for Assertio Therapeutics Inc are updated in real time on BlackAll Trade.
Assertio Therapeutics Inc trades at $23.50 (+0.09%). Real-time quotes and charts are available on BlackAll Trade.
Assertio Therapeutics Inc has a market cap of about $0.15B.
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the tre